MSAM
IMGN

Moloney Securities Asset Management’s Immunogen Inc IMGN Stock Holding History

Moloney Securities Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-274,450
Closed -$1.06M – 262
2017
Q1 		$1.06M Buy
274,450
+72,900
+36% +$213K 0.55% 46
2016
Q4 		$411K Buy
+201,550
New +$405K 0.25% 126

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Moloney Securities Asset Management's IMGN Position: Q2 2017 in Review

Moloney Securities Asset Management sold out of Immunogen Inc (IMGN) in Q2 2017, closing a stake of 274,450 shares — an estimated $1.06M sold.

Moloney Securities Asset Management first reported a position in IMGN in Q4 2016 and held it in 2 quarters. The position peaked at $1.06M in Q1 2017. 157 funds tracked by Wall St. Rank hold IMGN as of Q2 2017.

  • Moloney Securities Asset Management reported no remaining Immunogen Inc position as of Q2 2017 after selling out during the quarter.
  • Moloney Securities Asset Management sold 274,450 Immunogen Inc shares in Q2 2017, an estimated $1.06M.
  • Moloney Securities Asset Management first reported a position in Immunogen Inc in Q4 2016 and held it in 2 quarters.
  • Moloney Securities Asset Management's Immunogen Inc position peaked at $1.06M in Q1 2017.
  • 157 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2017.

Based on Moloney Securities Asset Management's 13F filing for Q2 2017, filed 25 Jul 2017.